Press Release Apr 12 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 12-Apr-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%.

View Attachment